Trial Profile
Comparative Study of Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV + Men Being Given Tenofovir With FTC, Emtricitabine (TRUVADA), or Without (VIREAD), as Part of Their Antiretroviral Therapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2016
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- 21 Nov 2016 Status changed from active, no longer recruiting to completed.
- 30 Sep 2015 Planned End Date changed from 1 Jun 2014 to 1 Jul 2016, as reported by ClinicalTrials.gov.
- 30 Sep 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.